Home › Therapeutic areas › Oncology › Acute Leukemia
Acute Leukemia (2 companies)
Companies with an active program in Acute Leukemia.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| KURA | Kura Oncology | MetabolicOncology | 1 | Approved | $647M | 12 |
| SNDX | Syndax Pharmaceuticals | ImmunologyOncology Rare | 1 | Approved | $852M | 7 |
No companies match.